SOFTFIL® PRECISION Micro-Cannula 25G/50mm

Manufacturing Information for Softfil Precision Micro-Cannula 25G/50mm

Softfil is a leading manufacturer based in France, specialising in micro-cannula technology. The Softfil Precision Micro-Cannulas line also includes:

• Softfil Precision Micro-Cannula 25G/60mm: Designed for deeper filler applications.
• Softfil Precision Micro-Cannula 25G/40mm: Suitable for medium-depth injections.
• Softfil Precision Micro-Cannula 22G/50mm: Ideal for high-viscosity fillers.
• Softfil Precision Micro-Cannula 22G/40mm: Offers precision for delicate areas.
• Softfil Precision Micro-Cannula 30G/25mm: Optimised for tear trough and fine-line treatments.

Expected Benefits and Results of the Treatments

Using Softfil Precision Micro-Cannula 25G/50mm provides several benefits for both practitioners and patients:

• Reduced bruising and swelling: Minimises vascular trauma.
• Increased patient comfort: Designed for less pain during procedures.
• Precise filler placement: Allows for even distribution and natural results.
• Lower risk of complications: Decreases the likelihood of vascular occlusion.
• Minimally invasive: Provides a smoother injection experience.

Softfil Precision Micro-Cannula 25G/50mm Materials and Device Properties

This micro-cannula is designed with premium materials to ensure safety and efficiency:

• Stainless steel: Provides durability and resistance to bending.
• Polyethylene: Ensures smooth insertion and flexibility for enhanced control.

Device properties:

• Blunt-tip design: Minimises tissue trauma.
• Flexible structure: Facilitates smoother movement under the skin.
• Precision gauge: Supports controlled filler injection.

Included Items or Accessories

Each package contains:

• 20 pre-hole sharp needles: Used for creating entry points before cannula insertion.
• 20 sterile micro-cannula kits: Individually packaged for safe, single-use application.

How to Store Softfil Precision Micro-Cannula 25G/50mm

To maintain sterility and product integrity, store properly:

• Keep in a cool, dry place away from direct sunlight, between 15°C and 25°C.
• Maintain original packaging to prevent contamination.
• Use before the expiry date for optimal safety.

Application Method for Softfil Precision Micro-Cannula 25G/50mm

Proper application ensures patient safety and optimal results.

Pre-procedure:

• Check packaging for any damage before use.
• Thoroughly disinfect the treatment area.
• Attach the micro-cannula securely to the syringe.
• Use the sharp pre-hole needle to create an entry point.

During procedure:

• Insert the micro-cannula through the entry point with controlled movements.
• Administer the filler evenly with gentle pressure.

After procedure:

• Dispose of the used cannula in a designated sharps container.
• Clean the injection site if necessary.
• Provide aftercare instructions to the patient.

Guidelines for Proper Aftercare

Aftercare is essential to maintain results and minimise complications:

• Avoid touching or massaging the treated area for 24 hours.
• Limit intense physical activity to reduce swelling.
• Apply cold compresses to minimise bruising.
• Stay hydrated to promote skin healing.
• Follow the practitioner’s specific post-treatment instructions.

Duration of Softfil Precision Micro-Cannula 25G/50mm

This product is for single use only and needs to be properly removed after application.

Potential Risks and Side Effects

While micro-cannulas reduce risks compared to traditional needles, some side effects may still occur:

• Mild swelling or redness: Typically resolves within a few days.
• Bruising at the injection site: Temporary and usually fades within a week.
• Discomfort: Minimal pain may occur post-procedure.
• Infection: Proper sterilisation reduces this risk.
• Allergic reactions: Rare but possible with some filler ingredients.
• Vascular occlusion: Requires immediate medical attention if it occurs.
• Temporary lumpiness or uneven texture: May occur due to filler placement and usually settles within a few days. 
• Itching or irritation: Mild sensitivity at the injection site may occur but typically subsides quickly. 
• Tenderness or soreness: Some patients may experience temporary discomfort in the treated area. 
• Skin discolouration: Minor pigmentation changes or temporary blanching can occur but usually fade over time. 
• Headache or dizziness: Rare but possible in sensitive individuals after the procedure. 
• Numbness or tingling: Temporary sensation changes may occur due to pressure on nerve endings. 
• Delayed-onset nodules: In rare cases, small lumps may appear weeks after treatment and require medical evaluation. 
• Tissue necrosis: Extremely rare but serious, this occurs when filler is inadvertently injected into a blood vessel, leading to skin damage.

Softfil Precision Micro-Cannula 25G/50mm Treatment Contraindications

Certain conditions and situations make this treatment unsuitable:

• Active infections or skin conditions: Increases the risk of complications and delayed healing.
• Recent facial surgery or treatments: May interfere with healing and lead to unpredictable results.
• Bleeding disorders: Higher risk of excessive bruising or hematoma formation.
• Blood-thinning medications: Patients taking anticoagulants or high-dose aspirin may experience excessive bleeding or bruising.
• Pregnancy and breastfeeding: Not recommended due to a lack of safety data.
• Compromised immune system: Patients with weakened immunity due to illness or medication may have a higher infection risk.
• Autoimmune diseases: Conditions such as lupus or rheumatoid arthritis may increase the risk of adverse reactions.
• Hypersensitivity to filler ingredients: May cause allergic reactions or severe irritation.
• Severe allergies or anaphylaxis history: Increased risk of an adverse reaction to the procedure or materials used.
• Active acne or skin inflammation: Can exacerbate skin irritation and increase infection risk.
• Recent vaccination or illness: Recent immune system activation may interfere with healing and increase the risk of reactions.
• Neurological disorders: Conditions such as myasthenia gravis or multiple sclerosis may impact the body’s response to treatment.
• Keloid or hypertrophic scarring history: Patients prone to excessive scarring may not be suitable candidates.
• Unrealistic expectations: Patients seeking exaggerated results or those with body dysmorphia may not be suitable candidates.